Cardiff Oncology

(NASDAQ) CRDF

Current Price$1.27

Market Cap$86.83M

Since IPO (2004)-100%

5 Year-80%

1 Year-65%

1 Month-16%

Cardiff Oncology Financials at a Glance

Market Cap

$86.83M

Revenue (TTM)

$525.00K

Net Income (TTM)

-$44.76M

EPS (TTM)

-$0.67

P/E Ratio

-1.91

Dividend

$0.00

Beta (Volatility)

1.74 (High)

Dividend

$0.00

Beta (Volatility)

1.74 (High)

Price

$1.27

Volume

54,734

Open

$1.28

Price

$1.27

Volume

54,734

Open

$1.28

Previous Close

$1.27

Daily Range

$1.20 - $1.31

52-Week Range

$1.16 - $4.56

Estimated Earnings Date

Aug 4, 2026

Dividend

$0.00

Beta (Volatility)

1.74 (High)

Price

$1.27

Volume

54,734

Open

$1.28

Previous Close

$1.27

Daily Range

$1.20 - $1.31

52-Week Range

$1.16 - $4.56

Estimated Earnings Date

Aug 4, 2026

CRDF News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardiff Oncology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Mani Mohindru, PhD

Website

www.cardiffoncology.com

Headquarters

San Diego, CA 92121, US

CRDF Financials

Key Financial Metrics (TTM)

Gross Margin

-2105.71%

Operating Margin

-9033.90%

Net Income Margin

-8526.10%

Return on Equity

-95.50%

Return on Capital

-105.93%

Return on Assets

-91.03%

Earnings Yield

-52.36%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$86.83M

Shares Outstanding

68.37M

Volume

54.73K

Avg. Volume

1.22M

Financials (TTM)

Gross Profit

-$11.06M

Operating Income

-$47.43M

EBITDA

-$43.73M

Operating Cash Flow

-$37.42M

Capital Expenditure

-$44.00K

Free Cash Flow

-$37.46M

Cash & ST Invst.

$46.06M

Total Debt

$646.00K

Cardiff Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$41.00K

-62.4%

Gross Profit

$41.00K

-62.4%

Gross Margin

100.00%

N/A

Market Cap

$86.83M

N/A

Market Cap/Employee

$2.80M

N/A

Employees

N/A

Net Income

-$12.35M

+8.1%

EBITDA

-$12.12M

+8.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$46.06M

-42.3%

Total Debt

$646.00K

-52.4%

Accounts Receivable

$191.00K

-52.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$646.00K

-9.8%

Return on Assets

-91.03%

N/A

Return on Invested Capital

-1.37%

N/A

Free Cash Flow

-$12.29M

+4.0%

Operating Cash Flow

-$12.29M

+4.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SAVACassava Sciences, Inc.

SAVACassava Sciences, Inc.$1.32+2.33%

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$3.22-37.35%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.32+0.00%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$9.25+1.98%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.76-2.76%

RANIRani Therapeutics Holdings, Inc.

RANIRani Therapeutics Holdings, Inc.$0.77+0.38%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$3.98+1.27%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

INTCIntel

INTCIntel$120.35-0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

ONDSOndas

ONDSOndas$7.41-0.06%

NOKNokia

NOKNokia$12.07-0.07%

RIVNRivian Automotive

RIVNRivian Automotive$18.63+0.08%

Questions About CRDF

What is the current price of Cardiff Oncology?

Cardiff Oncology is trading at $1.27 per share.

What is the 52-week range for Cardiff Oncology?

Over the past 52 weeks, Cardiff Oncology has traded between $1.16 and $4.56.

How much debt does Cardiff Oncology have?

As of the most recent reporting period, Cardiff Oncology reported total debt of $646.00K.

How much cash does Cardiff Oncology have on hand?

Cardiff Oncology reported $8.54M in cash and cash equivalents in its most recent financial results.

What is Cardiff Oncology’s dividend yield?

Cardiff Oncology does not currently have a dividend yield.

Cardiff Oncology

Cardiff Oncology Financials at a Glance

CRDF News

Cardiff Oncology (CRDF) Q2 Loss Down 19%

These 2 Nasdaq Stocks Are Poised to Make Big Moves Today

1 Cancer Stock on Buyout Watch in 2022

Why Cardiff Oncology Shares Were Up More Than 15% on Thursday

Why Shares of Cardiff Oncology Rose on Monday

Why Cardiff Oncology Ran Up 1,350% in 2020

Why Cardiff Oncology Stock Is Crashing Today

2 Biotech Stocks That Keep on Climbing

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cardiff Oncology

CRDF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cardiff Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CRDF

What is the current price of Cardiff Oncology?

What is the 52-week range for Cardiff Oncology?

How much debt does Cardiff Oncology have?

How much cash does Cardiff Oncology have on hand?

What is Cardiff Oncology’s dividend yield?

Premium Investing Services